Stocks · Health care · Pharmaceutical Preparations

ARDELYX, INC.

ARDX Clue Score56
United States Fiscal year ends December CIK 0001437402 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David M Mott
20 Feb 2026
Director
Buy
333,333
$5.84
$1.95M
David M Mott
16 Jun 2025
Director
Buy
200,000
$3.63
$725.88K
David M Mott
9 Jun 2025
Director
Buy
200,000
$3.69
$737.26K
David M Mott
15 May 2025
Director
Buy
100,000
$3.29
$329.12K
David M Mott
2 May 2025
Director
Buy
381,377
$4.22
$1.61M
David M Mott
24 Feb 2025
Director
Buy
77,729
$5.00
$388.74K
David M Mott
21 Jan 2025
Director
Buy
199,000
$4.99
$992.67K
David M Mott
19 Dec 2024
Director
Buy
213,300
$4.67
$996.58K
David M Mott
13 Nov 2024
Director
Buy
215,868
$4.62
$996.60K
Showing 250 of 443 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 508
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 44
Sales at will 346
Transactions with no price 0
Shares from compensation/vesting 41,416,740
Sales filed before the plan box existed 194
History held since 18 Jun 2014